Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
179 studies found for:    "Children's Hospital of Wisconsin"
Show Display Options
Rank Status Study
21 Completed The Second Multicenter Hemophilia Cohort Study
Conditions: Liver Decompensation;   Hepatocellular Carcinoma;   Non-Hodgkin Lymphoma
22 Recruiting Study to Evaluate a Single Dose of Apixaban in Pediatric Subjects at Risk for a Thrombotic Disorder
Condition: Thromboembolism
Intervention: Drug: Apixaban
23 Completed Vascular Malformations and Abnormalities of Growth
Condition: Abnormality
Intervention: Procedure: skin biopsy
24 Completed Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
Conditions: Pain;   Cancer;   Sickle Cell Anemia;   Severe Burns
Intervention: Drug: ACTIQ (Oral Transmucosal Fentanyl Citrate [OTFC])
25 Completed Effect of Early Rest on Recovery From Pediatric Concussion
Conditions: Mild Traumatic Brain Injury;   Concussion;   Post-concussive Syndrome
Intervention: Behavioral: Mandated Rest, Intervention
26 Active, not recruiting Video Education: Capitalizing on Caregiver Time Spent in the Pediatric Emergency Department Waiting Room
Condition: Child Passenger Seat Safety
Intervention: Other: Child passenger safety video
27 Completed The Influence of Expectations on Patient Satisfaction in the Pediatric Emergency Department
Condition: Patient Satisfaction
Intervention: Behavioral: Physician knowledge of parental expectations for the visit
28 Completed Natural History of Urticaria Pigmentosa in Children
Condition: Urticaria Pigmentosa
29 Enrolling by invitation The Use of L-Carnitine And CoQ10 Supplements In the Treatment of Cyclic Vomiting Syndrome (CVS)
Condition: Cyclic Vomiting Syndrome
30 Terminated Open-label Extension to Protocol 1042-0500
Condition: Infantile Spasms
Intervention: Drug: Ganaxolone
31 Recruiting PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Conditions: Phenylketonuria;   Hyperphenylalaninaemia
Intervention: Drug: Kuvan
32 Completed A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Conditions: Acute Lymphoblastic Leukemia;   Lymphoblastic Lymphoma
Intervention: Drug: asparaginase Erwinia chrysanthemi
33 Enrolling by invitation Monitoring Patient Cerebro-Spinal Fluid Drainage With an Ultrasonic Flow Sensor
Condition: Hydrocephalus
34 Recruiting Parent/Nurse Controlled Analgesia in the Neonatal Intensive Care Unit
Conditions: Abdominal Surgery;   Thoracic Surgery
Intervention: Drug: Morphine
35 Completed Transition From Hospital to Home in Solid Organ Transplant (SOT)
Condition: Solid Organ Transplant
36 Recruiting Discharge to Home and Chronic Illness Care Pilot
Condition: Solid Organ Transplant
Intervention: Behavioral: myFAMI iPad application
37 Completed Sedation Management in Pediatric Patients Supported on Mechanical Ventilation
Condition: Respiratory Failure
Intervention: Behavioral: Nurse Implemented Goal-Directed Comfort Algorithm
38 Completed
Has Results
Comparison of Two Types of Shunts in Infants With Single Ventricle Defect Undergoing Staged Reconstruction--Pediatric Heart Network
Condition: Heart Defects, Congenital
Interventions: Procedure: Blalock-Taussig pulmonary artery shunt;   Procedure: Right ventricular to pulmonary artery shunt
39 Recruiting Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders
Condition: Nonneoplastic Condition
Interventions: Biological: alemtuzumab;   Drug: fludarabine phosphate;   Radiation: total-body irradiation;   Drug: cyclosporine;   Drug: mycophenolate mofetil;   Procedure: allogeneic bone marrow transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation;   Other: laboratory biomarker analysis
40 Terminated
Has Results
Erythropoietin and Pediatric Cardiac Surgery
Condition: Congenital Heart Defect
Interventions: Drug: acyanotic erythropoietin;   Drug: acyanotic placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years